These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26241537)

  • 1. Efficacy of mesalazine or beclomethasone dipropionate enema or their combination in patients with distal active ulcerative colitis.
    Crispino P; Pica R; Unim H; Rivera M; Cassieri C; Zippi M; Paoluzi P
    Eur Rev Med Pharmacol Sci; 2015 Aug; 19(15):2830-7. PubMed ID: 26241537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study.
    Biancone L; Gionchetti P; Blanco Gdel V; Orlando A; Annese V; Papi C; Sostegni R; D'Incà R; Petruzziello C; Casa A; Sica G; Calabrese E; Campieri M; Pallone F
    Dig Liver Dis; 2007 Apr; 39(4):329-37. PubMed ID: 17347061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine: a single-blind randomized controlled trial.
    Gionchetti P; D'Arienzo A; Rizzello F; Manguso F; Maieron R; Lecis PE; Valpiani D; Iaquinto G; Annese V; Balzano A; Varoli G; Campieri M;
    J Clin Gastroenterol; 2005 Apr; 39(4):291-7. PubMed ID: 15758622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
    Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beclomethasone dipropionate (3 mg) versus 5-aminosalicylic acid (2 g) versus the combination of both (3 mg/2 g) as retention enemas in active ulcerative proctitis.
    Mulder CJ; Fockens P; Meijer JW; van der Heide H; Wiltink EH; Tytgat GN
    Eur J Gastroenterol Hepatol; 1996 Jun; 8(6):549-53. PubMed ID: 8823568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trial.
    Paoluzi P; D'Albasio G; Pera A; Bianchi Porro G; Paoluzi OA; Pica R; Cottone M; Miglioli M; Prantera C; Sturniolo G; Ardizzone S
    Dig Liver Dis; 2002 Nov; 34(11):787-93. PubMed ID: 12546514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study.
    Marteau P; Probert CS; Lindgren S; Gassul M; Tan TG; Dignass A; Befrits R; Midhagen G; Rademaker J; Foldager M
    Gut; 2005 Jul; 54(7):960-5. PubMed ID: 15951542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beclomethasone dipropionate (3 mg) enemas combined with oral 5-ASA (2.4 g) in the treatment of ulcerative colitis not responsive to oral 5-ASA alone.
    D'Arienzo A; Manguso F; Castiglione GN; Vicinanza G; Scaglione G; Bennato R; Sanges M; Mazzacca G
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):254-7. PubMed ID: 9759590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety of beclomethasone dipropionate in the treatment of ulcerative colitis.
    Rizzello F; Mazza M; Salice M; Calabrese C; Calafiore A; Campieri M; Gionchetti P
    Expert Opin Drug Saf; 2018 Sep; 17(9):963-969. PubMed ID: 30101623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral beclomethasone dipropionate in pediatric active ulcerative colitis: a comparison trial with mesalazine.
    Romano C; Famiani A; Comito D; Rossi P; Raffa V; Fries W
    J Pediatr Gastroenterol Nutr; 2010 Apr; 50(4):385-9. PubMed ID: 20179636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised trial comparing mesalazine and prednisolone foam enemas in patients with acute distal ulcerative colitis.
    Lee FI; Jewell DP; Mani V; Keighley MR; Kingston RD; Record CO; Grace RH; Daniels S; Patterson J; Smith K
    Gut; 1996 Feb; 38(2):229-33. PubMed ID: 8801202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, randomized multicentre study.
    Vecchi M; Meucci G; Gionchetti P; Beltrami M; Di Maurizio P; Beretta L; Ganio E; Usai P; Campieri M; Fornaciari G; de Franchis R
    Aliment Pharmacol Ther; 2001 Feb; 15(2):251-6. PubMed ID: 11148445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial: controlled, open, randomized multicentre study comparing the effects of treatment on quality of life, safety and efficacy of budesonide or mesalazine enemas in active left-sided ulcerative colitis.
    Hartmann F; Stein J;
    Aliment Pharmacol Ther; 2010 Aug; 32(3):368-76. PubMed ID: 20491741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Efficacy of Beclomethasone Dipropionate in Korean Patients with Ulcerative Colitis.
    Lee YJ; Cheon JH; Kim JH; Yoo S; Lee HJ; Park SJ; Hong SP; Kim TI; Kim WH
    Yonsei Med J; 2017 Jan; 58(1):144-149. PubMed ID: 27873507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new mesalazine foam enema (Claversal Foam) compared with a standard liquid enema in patients with active distal ulcerative colitis.
    Malchow H; Gertz B;
    Aliment Pharmacol Ther; 2002 Mar; 16(3):415-23. PubMed ID: 11876694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Beclomethasone Dipropionate versus 5-Aminosalicylic Acid in the Treatment of Ulcerative Colitis: A Systematic Review and Meta-Analysis.
    Zhao X; Li N; Ren Y; Ma T; Wang C; Wang J; You S
    PLoS One; 2016; 11(8):e0160500. PubMed ID: 27501314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled multicentre trial.
    Gionchetti P; Ardizzone S; Benvenuti ME; Bianchi Porro G; Biasco G; Cesari P; D'albasio G; De Franchis R; Monteleone G; Pallone F; Ranzi T; Trallori G; Valpiani D; Vecchi M; Campieri M
    Aliment Pharmacol Ther; 1999 Mar; 13(3):381-8. PubMed ID: 10102972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beclomethasone dipropionate enemas versus prednisolone sodium phosphate enemas in the treatment of distal ulcerative colitis.
    Campieri M; Cottone M; Miglio F; Manenti F; Astegiano M; D'Arienzo A; Manguso F; D'Albasio G; Bonanomi A; Galeazzi R; Orlando A; Castiglione GN; Gionchetti P
    Aliment Pharmacol Ther; 1998 Apr; 12(4):361-6. PubMed ID: 9690726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined oral and rectal mesalazine for the treatment of mild-to-moderately active ulcerative colitis: rapid symptom resolution and improvements in quality of life.
    Probert CS; Dignass AU; Lindgren S; Oudkerk Pool M; Marteau P
    J Crohns Colitis; 2014 Mar; 8(3):200-7. PubMed ID: 24012063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of mesalazine foam enema (Salofalk foam) for distal ulcerative colitis: a double-blind, randomized, placebo-controlled study.
    Pokrotnieks J; Marlicz K; Paradowski L; Margus B; Zaborowski P; Greinwald R
    Aliment Pharmacol Ther; 2000 Sep; 14(9):1191-8. PubMed ID: 10971236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.